Detalles de la búsqueda
1.
ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.
Clin Infect Dis
; 59(7): 1032-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24944232
2.
Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans.
Antimicrob Agents Chemother
; 57(8): 3536-46, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23669385
3.
Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers.
J Antimicrob Chemother
; 66(7): 1567-72, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21493648
4.
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.
Am Heart J
; 159(5): 716-29, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20435178
5.
Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.
Antimicrob Agents Chemother
; 53(4): 1532-8, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19188387
6.
Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.
Pharmacotherapy
; 32(4): 333-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22422361
7.
The effect of lopinavir/ritonavir and darunavir/ritonavir on the HIV integrase inhibitor S/GSK1349572 in healthy participants.
J Clin Pharmacol
; 51(2): 237-42, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20489027
8.
Lack of interaction between the HIV integrase inhibitor S/GSK1349572 and tenofovir in healthy subjects.
J Acquir Immune Defic Syndr
; 55(3): 365-7, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20585260
9.
Multidrug-resistant Enterococcus faecium in a patient with burns.
Clin Infect Dis
; 36(9): 1210-1, 2003 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12715325
10.
Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects.
Antimicrob Agents Chemother
; 52(2): 534-8, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18056271
11.
Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.
Am J Health Syst Pharm
; 65(5): 422-8, 2008 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18281734
12.
Safety and pharmacokinetics of GSK364735, a human immunodeficiency virus type 1 integrase inhibitor, following single and repeated administration in healthy adult subjects.
Antimicrob Agents Chemother
; 51(12): 4284-9, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17923489
13.
Pharmacokinetic and safety evaluation of high-dose combinations of fosamprenavir and ritonavir.
Antimicrob Agents Chemother
; 50(3): 928-34, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16495253
14.
Interaction between fosamprenavir, with and without ritonavir, and nevirapine in human immunodeficiency virus-infected subjects.
Antimicrob Agents Chemother
; 50(9): 3157-9, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16940117
15.
Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokinetics.
J Acquir Immune Defic Syndr
; 42(1): 61-7, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16639341
16.
Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women.
J Acquir Immune Defic Syndr
; 37(5): 1577-80, 2004 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15577412
17.
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction.
J Acquir Immune Defic Syndr
; 36(5): 1034-40, 2004 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15247556
Resultados
1 -
17
de 17
1
Próxima >
>>